PIERIS PHARMACEUTICALS, INC. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jun 15, 2016
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2016-06-13$1.68/sh+2,085$3,503→ 2,085 total - Purchase
Common Stock
2016-06-14$1.71/sh+7,915$13,535→ 10,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.72, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.